Phase 2 Rare Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 21 and 49 years old (inclusive).
- People who have used cannabis at least once in their lifetime AND have used cannabis three days or fewer in the 28 days before enrolling.
- People who are able to sign a consent form agreeing to take part.
- People who are willing to follow all study procedures, including avoiding cannabis products and all other drugs (except alcohol or nicotine) for 7 days before study visits.
- People whose lung function test result (measuring how much air can be breathed out in one second) is above 90%.
- People who can communicate and understand English or French.
- Female participants who cannot become pregnant, either because they have gone through menopause (no period for 12 months and are aged 45 or older) or have had a documented surgical procedure such as tubal ligation, hysterectomy, or removal of both ovaries.
- Female participants who could become pregnant, provided they have a negative pregnancy test at the start and at later visits, have no plans to become pregnant during the trial, and agree to use an accepted method of birth control throughout the study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with serious medical conditions identified through medical history, physical examination, vital signs, or laboratory tests that, in the study doctor's opinion, make safe participation or giving fully informed consent not possible.
- People with a severe psychiatric condition, such as a history of schizophrenia, schizoaffective disorder, or bipolar disorder, or who are currently experiencing acute psychosis, mania, suicidal thoughts, acute depression, or an acute anxiety disorder (as assessed using a standard psychiatric interview).
- People with any other serious, unstable, or acute mental health condition that, in the study doctor's opinion, makes safe participation or giving informed consent not possible.
- People with a known chronic liver disease, or whose liver enzyme levels (AST/ALT) are more than twice the upper limit of normal at the screening visit.
- People with a blood pressure reading higher than 130/80 mmHg.
- People with kidney disorders.
- People with bleeding disorders.
- People who currently have a moderate or severe substance use disorder (as defined by DSM-5 and assessed by a structured clinical interview), not including nicotine.
- People who are currently pregnant, breastfeeding, or planning to become pregnant at the time of screening or during the study.
- People with pending legal matters or any other reason that, in the study doctor's opinion, might prevent them from completing the study.
- People who have taken medication within 7 days before the experimental sessions that, in the investigator's opinion, may interact with cannabis.
- People who have taken part in a clinical study involving cannabis or cannabinoids in the 30 days before randomisation.
- People with a resting heart rate above 100 beats per minute.
- People with a body mass index (BMI) over 29.9 kg/m².
- People with any clinically significant abnormalities found on a heart trace (ECG) at the screening visit.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
If you need support right now
This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.
If you or someone else is in immediate danger, call 000.
- Lifeline — 24/7 crisis support: 13 11 14
- Suicide Call Back Service — 24/7 counselling: 1300 659 467
- 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
- Beyond Blue — 24/7 mental health support: 1300 22 4636
- Emergency: 000
Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.
Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.
Contact this trial
Principal Investigator: Didier Jutras-Aswad, MD,MS, Centre hospitalier de l'Université de Montréal (CHUM)
Phone: 514-890-8000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Pleasant drug effect; Pleasant drug effect; Pleasant drug effect
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.